240 related articles for article (PubMed ID: 20578122)
1. The development of artemisinin resistance in malaria: reasons and solutions.
Chrubasik C; Jacobson RL
Phytother Res; 2010 Jul; 24(7):1104-6. PubMed ID: 20578122
[TBL] [Abstract][Full Text] [Related]
2. Artemisinin resistance in Plasmodium falciparum: what is it really?
Ferreira PE; Culleton R; Gil JP; Meshnick SR
Trends Parasitol; 2013 Jul; 29(7):318-20. PubMed ID: 23768531
[TBL] [Abstract][Full Text] [Related]
3. Artemisinin derivatives and malaria: useful, in combination with other antimalarials.
Prescrire Int; 2008 Aug; 17(96):162-8. PubMed ID: 19492494
[TBL] [Abstract][Full Text] [Related]
4. Plasmodium falciparum resistance to artemisinin-based combination therapies: A sword of Damocles in the path toward malaria elimination.
Ouji M; Augereau JM; Paloque L; Benoit-Vical F
Parasite; 2018; 25():24. PubMed ID: 29676250
[TBL] [Abstract][Full Text] [Related]
5. Triple Artemisinin-Based Combination Therapies for Malaria - A New Paradigm?
van der Pluijm RW; Amaratunga C; Dhorda M; Dondorp AM
Trends Parasitol; 2021 Jan; 37(1):15-24. PubMed ID: 33060063
[TBL] [Abstract][Full Text] [Related]
6. Artemisinin resistance: current status and scenarios for containment.
Dondorp AM; Yeung S; White L; Nguon C; Day NP; Socheat D; von Seidlein L
Nat Rev Microbiol; 2010 Apr; 8(4):272-80. PubMed ID: 20208550
[TBL] [Abstract][Full Text] [Related]
7. Emerging artemisinin resistance in the border areas of Thailand.
Na-Bangchang K; Karbwang J
Expert Rev Clin Pharmacol; 2013 May; 6(3):307-22. PubMed ID: 23656342
[TBL] [Abstract][Full Text] [Related]
8. Artemisinin resistance in Plasmodium falciparum malaria.
Taylor SM; Juliano JJ; Meshnick SR
N Engl J Med; 2009 Oct; 361(18):1807; author reply 1808. PubMed ID: 19864681
[No Abstract] [Full Text] [Related]
9. Global estimation of anti-malarial drug effectiveness for the treatment of uncomplicated Plasmodium falciparum malaria 1991-2019.
Rathmes G; Rumisha SF; Lucas TCD; Twohig KA; Python A; Nguyen M; Nandi AK; Keddie SH; Collins EL; Rozier JA; Gibson HS; Chestnutt EG; Battle KE; Humphreys GS; Amratia P; Arambepola R; Bertozzi-Villa A; Hancock P; Millar JJ; Symons TL; Bhatt S; Cameron E; Guerin PJ; Gething PW; Weiss DJ
Malar J; 2020 Oct; 19(1):374. PubMed ID: 33081784
[TBL] [Abstract][Full Text] [Related]
10. Fighting fire with fire: mass antimalarial drug administrations in an era of antimalarial resistance.
von Seidlein L; Dondorp A
Expert Rev Anti Infect Ther; 2015 Jun; 13(6):715-30. PubMed ID: 25831482
[TBL] [Abstract][Full Text] [Related]
11. Artemisinin Action and Resistance in Plasmodium falciparum.
Tilley L; Straimer J; Gnädig NF; Ralph SA; Fidock DA
Trends Parasitol; 2016 Sep; 32(9):682-696. PubMed ID: 27289273
[TBL] [Abstract][Full Text] [Related]
12. Artemisinin-based combination treatment of falciparum malaria.
Nosten F; White NJ
Am J Trop Med Hyg; 2007 Dec; 77(6 Suppl):181-92. PubMed ID: 18165491
[TBL] [Abstract][Full Text] [Related]
13. Artemisinin resistance in Plasmodium falciparum malaria.
Htut ZW
N Engl J Med; 2009 Oct; 361(18):1807-8; author reply 1808. PubMed ID: 19877309
[No Abstract] [Full Text] [Related]
14. Antidogmatic approaches to artemisinin resistance: reappraisal as treatment failure with artemisinin combination therapy.
Krishna S; Kremsner PG
Trends Parasitol; 2013 Jul; 29(7):313-7. PubMed ID: 23623760
[TBL] [Abstract][Full Text] [Related]
15. A brief history of artemisinin: Modes of action and mechanisms of resistance.
Lu F; He XL; Richard C; Cao J
Chin J Nat Med; 2019 May; 17(5):331-336. PubMed ID: 31171267
[TBL] [Abstract][Full Text] [Related]
16. Plasmodium falciparum malaria: Convergent evolutionary trajectories towards delayed clearance following artemisinin treatment.
Wilairat P; Kümpornsin K; Chookajorn T
Med Hypotheses; 2016 May; 90():19-22. PubMed ID: 27063079
[TBL] [Abstract][Full Text] [Related]
17. Malaria resistance to non-artemisinin partner drugs: how to reACT.
van Schalkwyk DA; Sutherland CJ
Lancet Infect Dis; 2015 Jun; 15(6):621-3. PubMed ID: 25877961
[No Abstract] [Full Text] [Related]
18. Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study.
Spring MD; Lin JT; Manning JE; Vanachayangkul P; Somethy S; Bun R; Se Y; Chann S; Ittiverakul M; Sia-ngam P; Kuntawunginn W; Arsanok M; Buathong N; Chaorattanakawee S; Gosi P; Ta-aksorn W; Chanarat N; Sundrakes S; Kong N; Heng TK; Nou S; Teja-isavadharm P; Pichyangkul S; Phann ST; Balasubramanian S; Juliano JJ; Meshnick SR; Chour CM; Prom S; Lanteri CA; Lon C; Saunders DL
Lancet Infect Dis; 2015 Jun; 15(6):683-91. PubMed ID: 25877962
[TBL] [Abstract][Full Text] [Related]
19. Prevention and treatment of artemisinin-resistant falciparum malaria: update for international travellers.
Wkly Epidemiol Rec; 2010 May; 85(21):195-6. PubMed ID: 20514733
[No Abstract] [Full Text] [Related]
20. Quinine monotherapy for treating uncomplicated malaria in the era of artemisinin-based combination therapy: an appropriate public health policy?
Yeka A; Achan J; D'Alessandro U; Talisuna AO
Lancet Infect Dis; 2009 Jul; 9(7):448-52. PubMed ID: 19555904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
